Cagrilintide 5mg + Semaglutide 10mg Peptide Blend – Direct from Shanghai Manufacturer

The CagriSema combination—cagrilintide and semaglutide—represents the next frontier in metabolic research, offering scientists a powerful dual-therapy approach to investigating weight regulation, glucose homeostasis, and energy metabolism. By combining a long-acting amylin analog (cagrilintide) with a potent GLP-1 receptor agonist (semaglutide), this blend provides researchers with a comprehensive toolkit for studying the synergistic effects of complementary metabolic pathways.

If you are searching for “cagrilintide semaglutide blend for sale Australia” for your laboratory investigations, you need a manufacturing partner who understands the complexity of both peptides and can deliver the purity your studies demand. That partner is Shanghaia Peptides Co., Ltd.

We are a legitimate, licensed manufacturer operating from our headquarters at No. B Room 326, Jinhai Road 2588, Pudong District, Shanghai, China. Our facility is dedicated to the research, development, and production of high-purity peptide raw materials, catalog peptides, fluorescent dyes, and amino acids.

When you purchase our Cagrilintide 5mg + Semaglutide 10mg peptide blend from our platform, you are buying directly from the source—not a middleman or reseller.

Understanding CagriSema: The Synergistic Dual-Therapy Combination

The CagriSema combination brings together two of the most studied metabolic peptides, each targeting distinct but complementary pathways.

Cagrilintide – The Long-Acting Amylin Analog

Cagrilintide is a synthetic analog of the human hormone amylin, engineered for enhanced stability and extended half-life. It acts on amylin receptors to promote satiety, reduce food intake, and delay gastric emptying.

Semaglutide – The Potent GLP-1 Agonist

Semaglutide is a long-acting GLP-1 receptor agonist that supports appetite regulation, insulin secretion, glucagon suppression, and glucose metabolism.

Why the CagriSema Combination Matters in Research

The combination of cagrilintide and semaglutide has emerged as a groundbreaking research tool following promising clinical findings demonstrating synergistic effects on weight reduction and metabolic regulation.

Key Research Benefits

• Enhanced appetite suppression
• Improved glucose homeostasis
• Complementary receptor activation
• Once-weekly dosing potential
• Synergistic metabolic pathway research

Product Specifications

Cagrilintide Specifications

• Amount: 5mg
• CAS Number: 2685539-45-1
• Molecular Weight: Approximately 4,398.0 g/mol

Semaglutide Specifications

• Amount: 10mg
• CAS Number: 910463-68-2
• Molecular Weight: Approximately 4,113.6 g/mol

Blend Specifications

• Total Peptide Content: 15mg
• Form: Lyophilized powder
• Purity: ≥99% verified by HPLC
• Storage: -20°C protected from moisture and light
• Documentation: Batch-specific Certificates of Analysis

The Importance of High-Purity CagriSema Research Materials

When purchasing a cagrilintide semaglutide blend for sale in Australia, purity and consistency are critical. Accurate dosing and verified synthesis ensure reproducible laboratory outcomes.

The Shanghaia Peptides Quality Standard

• 99% Purity Guarantee
• HPLC & Mass Spectrometry Testing
• Amino Acid Sequence Verification
• Accurate Peptide Content Determination
• Batch-Specific COAs
• Stability Testing
• Endotoxin Testing Available

Why Researchers Choose Shanghaia Peptides

Direct Manufacturer Pricing

Purchase directly from our Shanghai manufacturing facility without reseller markups.

Advanced Manufacturing Expertise

Our experienced peptide synthesis team understands the complexities of metabolic peptide production and quality assurance.

Reliable Australian Supply Chain

We have optimized shipping specifically for Australian researchers and wholesale distributors.

• Fast shipping to Australia
• Cold-chain packaging
• Temperature-controlled handling
• Wholesale supply programs
• Secure international delivery

Research Applications

Obesity & Weight Regulation Research

• Appetite signaling studies
• Energy balance investigations
• Body composition analysis
• Adipose tissue research

Metabolic Research

• Glucose homeostasis
• Insulin sensitivity studies
• Lipid metabolism analysis
• Energy expenditure research

Type 2 Diabetes Research

• Glycemic control investigations
• Beta cell function studies
• Insulin secretion pathways

Receptor Pharmacology

• GLP-1 receptor activation
• Amylin receptor signaling
• Synergistic pathway analysis

Frequently Asked Questions

What is the Cagrilintide 5mg + Semaglutide 10mg blend?

This research-grade peptide blend combines cagrilintide and semaglutide for laboratory investigations into metabolic pathways, appetite regulation, and glucose homeostasis.

What purity levels are guaranteed?

We guarantee ≥99% purity verified by HPLC analysis with Certificates of Analysis available for every batch.

Is this product for human consumption?

No. This product is strictly supplied for laboratory and research purposes only and is not intended for human or veterinary use.

How should this blend be stored?

Store at -20°C away from moisture and direct light. Avoid repeated freeze-thaw cycles.

Do you ship throughout Australia?

Yes. We supply research institutions, laboratories, and wholesale partners across Australia.

Quality Control Standards

Every batch undergoes strict analytical testing including:

• HPLC purity analysis
• Mass spectrometry verification
• Peptide content testing
• Stability studies
• Water content analysis
• Endotoxin testing

Each shipment includes full documentation and batch traceability.

Your Trusted Australian Peptide Supply Partner

The search for premium “cagrilintide semaglutide blend for sale Australia” ends with Shanghaia Peptides Co., Ltd. We combine scientific expertise, advanced peptide manufacturing, and rigorous quality control to provide high-purity research materials trusted by laboratories worldwide.

Our Cagrilintide 5mg + Semaglutide 10mg peptide blend offers researchers a reliable and convenient combination for advanced metabolic and receptor pathway investigations.